Use of Antithrombin Concentrate in Stable Diffuse Intravascular Coagulation
- 1 January 1982
- journal article
- research article
- Published by S. Karger AG in Acta Haematologica
- Vol. 68 (1) , 28-33
- https://doi.org/10.1159/000206944
Abstract
A 39-yr-old woman suffering from a myelodysplastic syndrome, who developed a moderately severe stable diffuse intravascular coagulation (DIC) during an uneventful pregnancy, was studied. I.v. administration of antithrombin III concentrate was attempted to combat the DIC. Improved survival of platelet transfusions, facilitating supportive care, suggested some therapeutic benefit. Only minimal effects on the results of the coagulation tests were observed.This publication has 7 references indexed in Scilit:
- Antithrombin III Patterns in Disseminated Intravascular CoagulationAmerican Journal of Clinical Pathology, 1980
- ANTITHROMBIN-III TRANSFUSION IN DISSEMINATED INTRAVASCULAR COAGULATIONThe Lancet, 1978
- PLATELET TRANSFUSION THERAPY - OPTIMAL DONOR SELECTION WITH A COMBINATION OF LYMPHOCYTOTOXICITY AND PLATELET FLUORESCENCE TESTS1978
- Minimal Heparin Cofactor Activity in Disseminated Intravascular Coagulation and CirrhosisAmerican Journal of Clinical Pathology, 1976
- EFFECT OF VARIOUS ESTROGEN-TREATMENT SCHEDULES ON ANTITHROMBIN-3 LEVELS1976
- Inhibition of the Thrombin-fibrinogen Reaction by Antithrombin III, Studied by N-terminal AnalysisScandinavian Journal of Clinical and Laboratory Investigation, 1967
- Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodiesAnalytical Biochemistry, 1966